![]() NOW THEREFORE, in consideration of the foregoing premises and the mutual promises, covenants and conditions contained in this Agreement, the Parties agree as follows:Īs used in this Agreement, the following initially capitalized terms, whether used in the singular or plural form, shall have the meanings set forth in this Article 1.ġ.1 007 Composition Product means any Composition Product containing. Arrys and AskAt are sometimes referred to herein individually as a Party and collectively as the Parties.ĪskAt owns or otherwise controls certain materials, patents, patent applications, technology, know-how, scientific and technical information and other proprietary rights and information relating to EP4 Antagonists.ĪskAt owns certain patents and patent applications relating to methods of the treatment of cancer.Īrrys is a newly formed company that was formed for the purpose of entering into this Agreement.ĪskAt has agreed to grant to Arrys an exclusive license under the Licensed Technology to Exploit the Licensed Compounds and Licensed Products (all as defined below), and Arrys desires to receive such license, in accordance with the terms and conditions set forth herein. THIS LICENSE AGREEMENT (this Agreement) is entered into as of December 14, 2017 (the Effective Date) by and among Arrys Therapeutics, Inc., a corporation organized and existing under the laws of Delaware and having a principal place of business at c/o OrbiMed Advisors, LLC, 601 Lexington Avenue, 54 th Floor, New York, NY 10022 ( Arrys) and AskAt Inc., a company organized under the laws of Japan and having its principal place of business at, Nagoya, Japan, 466-0841 ( AskAt). ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
December 2022
Categories |